NERRE THERAPEUTICS LTD has a total of 73 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are DAMIAN PHARMA AG, IMPACT BIOMEDICINES INC and NEUROGASTRX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | Australia | 7 | |
#4 | Israel | 5 | |
#5 | South Africa | 5 | |
#6 | China | 4 | |
#7 | Japan | 4 | |
#8 | Serbia | 4 | |
#9 | WIPO (World Intellectual Property Organization) | 4 | |
#10 | Brazil | 3 | |
#11 | Canada | 3 | |
#12 | Hungary | 3 | |
#13 | Republic of Korea | 3 | |
#14 | Mexico | 3 | |
#15 | EAPO (Eurasian Patent Organization) | 2 | |
#16 | Hong Kong | 1 | |
#17 | Norway | 1 | |
#18 | Russian Federation | 1 | |
#19 | Singapore | 1 | |
#20 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Trower Mike | 21 |
#2 | Alvaro Giuseppe | 12 |
#3 | Michael Trower | 12 |
#4 | Emiliangelo Ratti | 11 |
#5 | Marasco Agostino | 10 |
#6 | Ratti Emiliangelo | 6 |
#7 | Lawrence Ronnie Maxwell | 6 |
#8 | Ismail Salima Zarah | 6 |
#9 | Mike Trower | 5 |
#10 | Trower Michael | 4 |
Publication | Filing date | Title |
---|---|---|
WO2018197638A1 | Novel use of (5r)-5-[5-[{2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoyl}(methyl)amino]-4-(4-fluoro-2-methylphenyl)-2-pyridinyl]-2-methyl-d-prolinamide | |
US2017326141A1 | Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents | |
AU2016384267A1 | Orvepitant for the treatment of chronic cough | |
CN104703603A | Novel uses |